Published in Int Surg on March 01, 2015
Human gastric carcinogenesis: a multistep and multifactorial process--First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res (1992) 12.77
TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2006) 5.86
Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinoma: a clinicopathologic study. Gastroenterology (1993) 4.04
TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system. Virchows Arch (2007) 3.89
Mixed Adenoneuroendocrine Carcinomas (MANECs) of the Gastrointestinal Tract: An Update. Cancers (Basel) (2012) 1.90
Increased oxidative DNA damage in Helicobacter pylori-infected human gastric mucosa. Cancer Res (1996) 1.89
A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem? Am J Gastroenterol (2004) 1.67
Carcinoid tumors of the gastrointestinal tract: trends in incidence in England since 1971. Am J Gastroenterol (2010) 1.65
Neuroendocrine tumors of the stomach (gastric carcinoids) are on the rise: small tumors, small problems? Endoscopy (2010) 1.60
Review article: Pathogenesis and management of gastric carcinoid tumours. Aliment Pharmacol Ther (2006) 1.57
Neuroendocrine gastroenteropancreatic tumours: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol (2010) 1.30
Concurrent occurrence of adenocarcinoma and carcinoid tumor in the stomach: a composite tumor or collision tumors? Am J Clin Pathol (1985) 1.28
Signet ring cells in gastric carcinomas are derived from neuroendocrine cells. J Histochem Cytochem (2005) 1.10
Mixed (composite) glandular-endocrine cell carcinoma of the stomach. Report of a case and review of literature. Am J Surg Pathol (1991) 1.07
A prospective evaluation of the effect of chronic proton pump inhibitor use on plasma biomarker levels in humans. Pancreas (2012) 0.96
The classification of chronic gastritis: current status. J Clin Gastroenterol (1995) 0.92
Immunopathology of Helicobacter pylori gastritis. Digestion (1997) 0.91
Current pharmacotherapy options for gastritis. Expert Opin Pharmacother (2012) 0.89
Composite signet-ring cell/neuroendocrine carcinoma of the stomach with a metastatic neuroendocrine carcinoma component: a better prognosis entity. Diagn Pathol (2007) 0.88
Gastritis. Springer Semin Immunopathol (1990) 0.85
Gastric carcinoids after long-term use of a proton pump inhibitor. Aliment Pharmacol Ther (2012) 0.85
Helicobacter pylori, gastric cancer and gastric epithelial kinetics: a review. Eur J Gastroenterol Hepatol (1995) 0.84
Hypergastrinemia and enterochromaffin-like cell hyperplasia. Yale J Biol Med (1999) 0.83
Differential proteomics of Helicobacter pylori associated with autoimmune atrophic gastritis. Mol Med (2014) 0.82
Multifocal early gastric cancer in a patient with autoimmune atrophic gastritis and iron deficiency anaemia. Z Gastroenterol (2009) 0.82
Meta-analyses: does long-term PPI use increase the risk of gastric premalignant lesions? Arch Iran Med (2013) 0.81
Safety profile of Lansoprazole: the US clinical trial experience. Drug Saf (1999) 0.79
Mutations of the epidermal growth factor receptor gene in lung cancer: biological and clinical implications. Cancer Res (2004) 7.76
Analysis of epidermal growth factor receptor gene mutation in patients with non-small cell lung cancer and acquired resistance to gefitinib. Clin Cancer Res (2006) 4.62
The APC tumor suppressor counteracts beta-catenin activation and H3K4 methylation at Wnt target genes. Genes Dev (2006) 3.85
The diagnosis and treatment of adult intussusception. J Clin Gastroenterol (2003) 3.06
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study). Lancet Oncol (2010) 2.73
Inhibition of autophagy by 3-MA enhances the effect of 5-FU-induced apoptosis in colon cancer cells. Ann Surg Oncol (2008) 2.56
High incidence of microscopic gastrointestinal stromal tumors in the stomach. Hum Pathol (2006) 2.23
Laparoscopic assisted distal gastrectomy for early gastric cancer: Five years' experience. Surgery (2005) 2.06
Inhibition of autophagy augments 5-fluorouracil chemotherapy in human colon cancer in vitro and in vivo model. Eur J Cancer (2010) 1.93
Prognostic model of pulmonary adenocarcinoma by expression profiling of eight genes as determined by quantitative real-time reverse transcriptase polymerase chain reaction. J Clin Oncol (2004) 1.89
IL-15 regulates CD8+ T cell contraction during primary infection. J Immunol (2006) 1.88
Evaluation of 18F-2-deoxy-2-fluoro-D-glucose positron emission tomography for gastric cancer. World J Surg (2004) 1.87
Prognostic implication of EGFR, KRAS, and TP53 gene mutations in a large cohort of Japanese patients with surgically treated lung adenocarcinoma. J Thorac Oncol (2009) 1.85
Thoracic and cardiovascular surgery in Japan during 2011: Annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2013) 1.84
Laparoscopically assisted total gastrectomy with lymph node dissection for upper and middle gastric cancer. Surg Endosc (2008) 1.82
Activation of MET by gene amplification or by splice mutations deleting the juxtamembrane domain in primary resected lung cancers. J Thorac Oncol (2009) 1.81
Gum chewing enhances early recovery from postoperative ileus after laparoscopic colectomy. J Am Coll Surg (2002) 1.77
c-myc is a downstream target of the Smad pathway. J Biol Chem (2001) 1.74
EphA2 overexpression correlates with poor prognosis in esophageal squamous cell carcinoma. Int J Cancer (2003) 1.68
Thoracic and cardiovascular surgery in Japan during 2012 : annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2014) 1.65
Laparoscopy-assisted proximal gastrectomy with gastric tube reconstruction for early gastric cancer. Surg Endosc (2010) 1.65
The incremental effect of positron emission tomography on diagnostic accuracy in the initial staging of esophageal carcinoma. Cancer (2005) 1.64
Biological and genetic characteristics of tumor-initiating cells in colon cancer. Ann Surg Oncol (2007) 1.62
Gastrointestinal stromal tumors of neurofibromatosis type I (von Recklinghausen's disease). Am J Surg Pathol (2005) 1.58
Should patients over 85 years old be operated on for colorectal cancer? J Clin Gastroenterol (2004) 1.52
Overexpression of IL-15 in vivo increases antigen-driven memory CD8+ T cells following a microbe exposure. J Immunol (2002) 1.51
PTEN and PIK3CA expression is associated with prolonged survival after gefitinib treatment in EGFR-mutated lung cancer patients. J Thorac Oncol (2006) 1.50
TP53 mutations in nonsmall cell lung cancer. J Biomed Biotechnol (2011) 1.46
Adenovirus-mediated overexpression of the activin betaC subunit accelerates liver regeneration in partially hepatectomized rats. J Hepatol (2005) 1.45
Mechanisms of resistance to EGFR TKIs and development of a new generation of drugs in non-small-cell lung cancer. J Biomed Biotechnol (2011) 1.42
Impact of gastropyloric motor activity on the genesis of reflux esophagitis after an esophagectomy with gastric tube reconstruction. Ann Thorac Surg (2013) 1.42
Development of gastric carcinoma from intestinal metaplasia in Cdx2-transgenic mice. Cancer Res (2004) 1.41
Gastrointestinal recovery and outcome after laparoscopy-assisted versus conventional open distal gastrectomy for early gastric cancer. World J Surg (2002) 1.41
Primary omental gastrointestinal stromal tumor (GIST). World J Surg Oncol (2007) 1.39
Is an elderly recipient a risk for living donor adult liver transplantation? Hepatogastroenterology (2008) 1.38
p53-Altered FBXW7 expression determines poor prognosis in gastric cancer cases. Cancer Res (2009) 1.37
Thoracic and cardiovascular surgery in Japan during 2009: annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2011) 1.35
MicroRNA miR-125b is a prognostic marker in human colorectal cancer. Int J Oncol (2011) 1.34
Heparin cofactor II is a novel protective factor against carotid atherosclerosis in elderly individuals. Circulation (2004) 1.32
Expression of cancer/testis (CT) antigens in lung cancer. Lung Cancer (2003) 1.31
High-level expression of the Smad ubiquitin ligase Smurf2 correlates with poor prognosis in patients with esophageal squamous cell carcinoma. Cancer Res (2002) 1.30
Plastin3 is a novel marker for circulating tumor cells undergoing the epithelial-mesenchymal transition and is associated with colorectal cancer prognosis. Cancer Res (2013) 1.29
Thoracoscopic treatment of Bochdalek hernia in the adult: report of a case. Ann Thorac Cardiovasc Surg (2002) 1.29
Comparison between positron emission tomography and computed tomography in the use of the assessment of esophageal carcinoma. Cancer (2002) 1.28
MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci (2012) 1.27
SKIP interacts with c-Myc and Menin to promote HIV-1 Tat transactivation. Mol Cell (2009) 1.26
Distal pancreatectomy: is staple closure beneficial? ANZ J Surg (2003) 1.25
Laparoscopic appendectomy for appendiceal endometriosis presenting as acute appendicitis: report of a case. Surg Today (2007) 1.25
Selenium enrichment of broccoli sprout extract increases chemosensitivity and apoptosis of LNCaP prostate cancer cells. BMC Cancer (2009) 1.25
Disruption of nuclear vitamin D receptor gene causes enhanced thrombogenicity in mice. J Biol Chem (2004) 1.24
Thoracic and cardiovascular surgery in Japan during 2008: annual report by The Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2010) 1.24
Prognostic and predictive implications of HER2/ERBB2/neu gene mutations in lung cancers. Lung Cancer (2011) 1.23
18F-fluorodeoxyglucose positron emission tomography: useful technique for predicting malignant potential of gastrointestinal stromal tumors. World J Surg (2005) 1.22
Transient gene silencing of galectin-3 suppresses pancreatic cancer cell migration and invasion through degradation of β-catenin. Int J Cancer (2011) 1.21
Preoperative diagnosis of lymph node metastases of colorectal cancer by FDG-PET/CT. Jpn J Clin Oncol (2008) 1.18
Reduced expression of transforming growth factor-beta receptors is an unfavorable prognostic factor in human esophageal squamous cell carcinoma. Int J Cancer (2003) 1.17
Expression of EphA2 and E-cadherin in colorectal cancer: correlation with cancer metastasis. Oncol Rep (2004) 1.16
Schwannoma of the breast: report of a case. Surg Today (2005) 1.16
Safe and effective sedation in endoscopic submucosal dissection for early gastric cancer: a randomized comparison between propofol continuous infusion and intermittent midazolam injection. J Gastroenterol (2010) 1.15
Implication of galectin-3 in Wnt signaling. Cancer Res (2005) 1.12
Prognostic significance of EpCAM expression in human esophageal cancer. Int J Oncol (2007) 1.11
Primary squamous cell carcinoma of the stomach: a case report with immunohistochemical and molecular biologic studies. Hepatogastroenterology (2005) 1.10
Rationale for antiangiogenic cancer therapy with vaccination using epitope peptides derived from human vascular endothelial growth factor receptor 2. Cancer Res (2005) 1.10
Predictive and prognostic role of activated mammalian target of rapamycin in cervical cancer treated with cisplatin-based neoadjuvant chemotherapy. Oncol Rep (2006) 1.09
Three-dimensional kinetic analysis of side-foot and instep soccer kicks. Med Sci Sports Exerc (2002) 1.09
Expression of an activated mammalian target of rapamycin in adenocarcinoma of the cervix: A potential biomarker and molecular target therapy. Mol Carcinog (2008) 1.07
Hepatocellular carcinoma producing a granulocyte colony-stimulating factor: report of a resected case with a literature review. Liver Int (2007) 1.07
The clinical application of (18)F-fluorodeoxyglucose positron emission tomography to predict survival in patients with operable esophageal cancer. Cancer (2009) 1.07
Thoracic and cardiovascular surgery in Japan during 2007. Annual report by the Japanese Association for Thoracic Surgery. Gen Thorac Cardiovasc Surg (2009) 1.07
CD24 expression is a novel prognostic factor in esophageal squamous cell carcinoma. Ann Surg Oncol (2008) 1.06
Autocrine motility factor signaling enhances pancreatic cancer metastasis. Clin Cancer Res (2004) 1.06
Comparison between whole-body positron emission tomography and bone scintigraphy in evaluating bony metastases of esophageal carcinomas. Anticancer Res (2005) 1.06
Identification of overexpressed genes in hepatocellular carcinoma, with special reference to ubiquitin-conjugating enzyme E2C gene expression. Int J Cancer (2007) 1.05
Nuclear beta-catenin expression at the invasive front and in the vessels predicts liver metastasis in colorectal carcinoma. Anticancer Res (2008) 1.05
Esophageal granular cell tumor covered by intramucosal squamous cell carcinoma: report of a case. Surg Today (2008) 1.05
Gastric schwannomas show an obviously increased fluorodeoxyglucose uptake in positron emission tomography: report of two cases. Surg Today (2011) 1.05
Nuclear karyopherin-α2 expression in primary lesions and metastatic lymph nodes was associated with poor prognosis and progression in gastric cancer. Carcinogenesis (2013) 1.05
Molecular processes of chromosome 9p21 deletions in human cancers. Oncogene (2003) 1.05
Increased expression of c-Ski as a co-repressor in transforming growth factor-beta signaling correlates with progression of esophageal squamous cell carcinoma. Int J Cancer (2004) 1.04
Significance of karyopherin-{alpha} 2 (KPNA2) expression in esophageal squamous cell carcinoma. Anticancer Res (2010) 1.04
Predictive value of blood flow in the gastric tube in anastomotic insufficiency after thoracic esophagectomy. World J Surg (2002) 1.04
Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Ann Surg Oncol (2007) 1.03
PKC theta, a novel immunohistochemical marker for gastrointestinal stromal tumors (GIST), especially useful for identifying KIT-negative tumors. Pathol Int (2005) 1.03
alpha1-acid glycoprotein fucosylation as a marker of carcinoma progression and prognosis. Cancer (2004) 1.03
c-kit gene mutations in intracranial germinomas. Cancer Sci (2004) 1.02
Endoscopic submucosal dissection (ESD) for colorectal tumors. Dig Endosc (2009) 1.02
Epstein-Barr virus-associated gastric carcinoma in the remnant stomach: de novo and metachronous gastric remnant carcinoma. J Gastroenterol (2005) 1.02
Clinicopathological significance of stanniocalcin 2 gene expression in colorectal cancer. Int J Cancer (2009) 1.02
Laparoscopy-assisted gastrectomy for early gastric cancer in young and elderly patients. World J Surg (2005) 1.02
Stathmin1 regulates p27 expression, proliferation and drug resistance, resulting in poor clinical prognosis in cholangiocarcinoma. Cancer Sci (2014) 1.01
Thickness of subcutaneous fat as a strong risk factor for wound infections in elective colorectal surgery: impact of prediction using preoperative CT. Dig Surg (2010) 1.01
The role of P-glycoprotein in intestinal tumorigenesis: disruption of mdr1a suppresses polyp formation in Apc(Min/+) mice. Carcinogenesis (2003) 0.99
Prolyl isomerase Pin1 expression predicts prognosis in patients with esophageal squamous cell carcinoma and correlates with cyclinD1 expression. Int J Oncol (2006) 0.99
Nonendothelial mesenchymal cell-derived MCP-1 is required for FGF-2-mediated therapeutic neovascularization: critical role of the inflammatory/arteriogenic pathway. Arterioscler Thromb Vasc Biol (2006) 0.99
Enforced expression of Bcl-2 partially restores cell numbers but not functions of TCRgammadelta intestinal intraepithelial T lymphocytes in IL-15-deficient mice. J Immunol (2007) 0.99
Comparing endoscopic submucosal dissection with transanal resection for non-invasive rectal tumor: a retrospective study. J Gastroenterol Hepatol (2011) 0.99